Mark Tawa
9Patents
3h-index
15Co-inventors
46Inventor score
Filing activity: Dec 24, 2003 → Apr 3, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7790905B2 | Pharmaceutical propylene glycol solvate compositions | Chemistry; Metallurgy | 32 | Active |
| US8198268B2 | Tianeptine sulfate salt forms and methods of making and using the same | Human Necessities | 11 | Active |
| US8436029B2 | Pharmaceutical forms, and methods of making and using the same | Chemistry; Metallurgy | 7 | Active |
| US8362062B2 | Pharmaceutical compositions with improved dissolution | Chemistry; Metallurgy | 2 | Active |
| US8183290B2 | Pharmaceutically acceptable propylene glycol solvate of naproxen | Human Necessities | 2 | Active |
| US8754093B2 | Co-crystal of etravirine and nicotinamide | Chemistry; Metallurgy | 0 | Active |
| US8410287B2 | Hydrated sodium salt form of celecoxib | Human Necessities | 0 | Active |
| US8492423B2 | Pharmaceutical propylene glycol solvate compositions | Human Necessities | 0 | Active |
| US7186863B2 | Sertraline compositions | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.